Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac cachexia.

Stefan D Anker1, Wolfram Steinborn, Sabine Strassburg

  • 1Department of Clinical Cardiology National Heart & Lung Institute, Imperial College London, UK. s.anker@imperial.ac.uk

Annals of Medicine
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.

Journal of cachexia, sarcopenia and muscle·2015
Same author

Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure.

Journal of cachexia, sarcopenia and muscle·2015
Same author

Cachexia: a nutritional syndrome?

Journal of cachexia, sarcopenia and muscle·2015
Same author

Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin.

Journal of cachexia, sarcopenia and muscle·2015
Same author

Biomarkers for physical frailty and sarcopenia: state of the science and future developments.

Journal of cachexia, sarcopenia and muscle·2015
Same author

Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients.

Journal of the American Society of Nephrology : JASN·2015

Cardiac cachexia, a serious complication of chronic heart failure (CHF), involves body wasting and poor prognosis. This condition results from complex metabolic, neurohormonal, and immune system imbalances.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Neuroendocrinology

Background:

  • Chronic heart failure (CHF) is a growing public health concern, characterized by complex systemic effects.
  • Cardiac cachexia, a severe complication of CHF, involves significant loss of body mass (fat, lean, bone tissue).
  • Cachectic CHF patients exhibit reduced muscle mass and quality, leading to weakness and early fatigue.

Purpose of the Study:

  • To explore the pathophysiological mechanisms underlying cardiac cachexia in chronic heart failure.
  • To investigate the role of metabolic, neurohormonal, and immune system abnormalities in the development of cardiac cachexia.

Main Methods:

  • Review of existing evidence on the pathophysiology of cardiac cachexia.
  • Analysis of correlations between body wasting and neurohormonal/immune markers.

Related Experiment Videos

Main Results:

  • Cardiac cachexia is associated with a poor prognosis, independent of disease severity or cardiac function.
  • Cachectic CHF patients display elevated levels of stress hormones (epinephrine, norepinephrine, cortisol) and renin-aldosterone.
  • Increased levels of inflammatory cytokines, such as tumor necrosis factor alpha, are linked to cardiac cachexia.

Conclusions:

  • Cardiac cachexia is a multifactorial disorder driven by neuroendocrine and metabolic dysregulation.
  • Imbalances in the neurohormonal and immune systems significantly contribute to body wasting in CHF.
  • Understanding these complex interactions is crucial for improving outcomes in cachectic CHF patients.